Clinical outcome of children with newly diagnosed acute lymphoblastic leukemia treated in a single center in Shanghai, China

References

• Long Jun Gu. Treatment of childhood acute leukemia with regular standard protocol to improve long-term disease free survival rate. Chinese J Hematol 1999; 20: 341–342
   Google Scholar
• Bennett J M, Catovsky D, Daniel M T, Flandrin G, Galton D A, Gralnick H R, et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) cooperative group. Br J Haematol 1976; 33: 451–458
   PubMed Web of Science ®Google Scholar
• van der Does-van den Berg A, Bartram C R, Basso G, Benoit Y C, Biondi A, Debatin K M, et al. Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the “BFM Family” Cooperative Group. Med Pediatr Oncol 1992; 20: 497–505
   PubMedGoogle Scholar
• Ludwig W D, Rieder H, Bartram C R, Heinze B, Schwartz S, Gassmann W, et al. Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89. Blood 1998; 92: 1898–1909
   PubMed Web of Science ®Google Scholar
• Bene M C, Castoldi G, Knapp W, Ludwig W D, Matutes E, Orfao A, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995; 9: 1783–1786
   PubMed Web of Science ®Google Scholar
• Harbott J, Ritterbach J, Ludwig W-D, Bartram C R, Reiter A, Lampert F. Clinical significance of cytogenetic studies in childhood acute lymphoblastic leukemia: experience of the BFM trials. Recent Results Cancer Res 1993; 131: 123–132
   PubMedGoogle Scholar
• ISCN 1995. An International System for Human Cytogenetic Nomenclature, F Mitelman. Karger, Basel 1995
   Google Scholar
• Tsurusawa M, Katano N, Fujimoto T. Prognosis and DNA aneuploidy in children with acute lymphoblastic leukemia. Haematol Blood Transfus 1990; 33: 174–181
   PubMedGoogle Scholar
• Hui Ye, Long-jun Gu, Jing Chen, Hui-liang Xue, Yuhong Tong, Juan Qian, et al. Approach on CF protocol after high-dose MTX vein drop. Chinese J Hematol 2000; 21: 92–93
   Google Scholar
• Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481
   Web of Science ®Google Scholar
• Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163–170
   PubMedGoogle Scholar
• Pui C-H, Boyett J M, Rivera G K, Hancock M L, Sandlund J T, Ribeiro R C, et al. Long-term results of total therapy studies 11, 12 and 13A for childhood acute leukemia at St Jude Children's Research Hospital. Leukemia 2000; 14: 2286–2294
   PubMed Web of Science ®Google Scholar
• Schrappe M, Reiter A, Zimmermann M, Harbott J, Ludwig W D, Henze G, et al. Long-term results of four consecutive trials in childhood ALL. Performed by the ALL-BFM study group from 1981 to 1995. Leukemia 2000; 14: 2205–2222
   PubMed Web of Science ®Google Scholar
• Gaynon P S, Trigg M E, Heerema N A, Sensel M G, Sather H N, Hammond G D, et al. Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983 – 1995. Leukemia 2000; 14: 2223–2233
   PubMed Web of Science ®Google Scholar
• Eden O B, Harrsion G, Richards S, Lilleyman J S, Bailey C C, Chessells J M, et al. Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukemia, 1980 – 1997. Medical Research Council Childhood Leukaemia Working Party. Leukemia 2000; 14: 2307–2320
   Google Scholar
• Harms D O, Janka-Schaub G E. Co-operative study of the childhood acute lymphoblastic leukemia (COALL): long-term follow-up trials 82, 85, 89, and 92. Leukemia 2000; 14: 2234–2239
   PubMed Web of Science ®Google Scholar
• Tsuchida M, Ikuta K, Hanada R, Saito T, Isoyama K, Sugita K, et al. Long-term follow-up of childhood acute lymphoblastic leukemia in Tokyo Children's Cancer Study Group 1981 – 1995. Leukemia 2000; 14: 2295–2306
   PubMed Web of Science ®Google Scholar
• Pui C H, Sandlund J T, Pei D, Campana D, Rivera G K, Ribeiro R C, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood 2004; 104: 2690–2696
   PubMed Web of Science ®Google Scholar
• Long Jun Gu, Hui-yu Yao, Hui-liang Xue, Huijun Zhao, Yaoping Wang, Meiyu Gu, et al. Clinical result of 57 cases of childhood acute lymphoblastic leukemia treated with ALL-XH-88 protocol of early continuous intensified chemotherapy. Chinese J Hematol 1994; 15: 76–79
   Google Scholar
• Pui C H, Simone J V, Hancock M L, Evans W E, Williams D L, Bowman W P, et al. Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: long-term results of St. Jude Total Therapy Study X. Leukemia 1992; 6: 150–157
   PubMed Web of Science ®Google Scholar
• Masson E, Relling M V, Synold T W, Liu Q, Schuetz J D, Sandlund J T, et al. Accumulation of methotrexate polyglutamates in lymphoblasts is determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate. J Clin Invest 1996; 97: 73–80
   PubMed Web of Science ®Google Scholar
• Reiter A, Schrappe M, Ludwig W D, Hiddemann W, Sauter S, Henze G, et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994; 84: 3122–3133
   PubMed Web of Science ®Google Scholar
• Lange B J, Bostrom B C, Cherlow J M, Sensel M G, La M K, Rackoff W, et al. Double delayed intensification improves EFS for children with intermediate risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 2002; 99: 825–833
   PubMed Web of Science ®Google Scholar
• Pui C-H, Evans W E. Treatment for acute lymphoblastic leukemia. N Engl J Med 2006; 354: 166–178
   PubMed Web of Science ®Google Scholar
• Schrappe M, Reiter A, Ludwig W D, Harbott J, Zimmermann M, Hiddemann W, et al. Improved outcome in childhood ALL despite reduced use of anthracyclines and of cranial radiotherapy: results of trial ALL-BFM 90. Blood 2000; 95: 3310–3322
   PubMed Web of Science ®Google Scholar
• Pui C-H, Campana D, Evans W E. Childhood acute lymphoblastic leukemia current status and future perspectives. Lancet Oncol 2001; 2: 597–607
   PubMed Web of Science ®Google Scholar
• Gaynon P S, Desai A A, Bostrom B C, Hutchinson R J, Lange B J, Nachman J B, et al. Early response to therapy and outcome in childhood acute lymphoblastic leukemia. Cancer 1997; 80: 1717–1726
   PubMed Web of Science ®Google Scholar
• Moghrabi A, Levy D E, Asselin B, Barr R, Clavell L, Hurwitz C, et al. Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood 2007; 109: 896–904
   PubMed Web of Science ®Google Scholar